Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002018445-25-000002
Filing Date
2025-03-18
Accepted
2025-03-18 09:29:27
Documents
1
Effectiveness Date
2025-03-18
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15998
  Complete submission text file 0002018445-25-000002.txt   17422
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-541194 | Film No.: 25746698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)